ID   WM1346
AC   CVCL_W886
SY   WM-1346; WM 1346; WC00121
DR   cancercelllines; CVCL_W886
DR   Coriell; WC00121
DR   Cosmic; 1155538
DR   GEO; GSM109024
DR   GEO; GSM185170
DR   GEO; GSM185171
DR   GEO; GSM185172
DR   GEO; GSM185173
DR   Progenetix; CVCL_W886
DR   Wikidata; Q54994167
RX   PubMed=16827748;
RX   PubMed=18632627;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: Coriell; WC00121; probable.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 11
//
RX   PubMed=16827748; DOI=10.1111/j.1600-0749.2006.00322.x;
RA   Hoek K.S., Schlegel N.C., Brafford P., Sucker A., Ugurel S., Kumar R.,
RA   Weber B.L., Nathanson K.L., Phillips D.J., Herlyn M., Schadendorf D.,
RA   Dummer R.;
RT   "Metastatic potential of melanomas defined by specific gene expression
RT   profiles with no BRAF signature.";
RL   Pigment Cell Res. 19:290-302(2006).
//
RX   PubMed=18632627; DOI=10.1158/0008-5472.CAN-08-0235;
RA   Smalley K.S.M., Contractor R., Nguyen T.K., Xiao M., Edwards R.,
RA   Muthusamy V., King A.J., Flaherty K.T., Bosenberg M.W., Herlyn M.,
RA   Nathanson K.L.;
RT   "Identification of a novel subgroup of melanomas with
RT   KIT/cyclin-dependent kinase-4 overexpression.";
RL   Cancer Res. 68:5743-5752(2008).
//